MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tics(also see Gilles de la Tourette syndrome): Treatment"

  • 2016 International Congress

    Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study

    R. Miguel, M. Mendonça, R. Barbosa, F. Ladeira, T. Lampreia, J. Vale, P. Bugalho (Lisbon, Portugal)

    Objective: To assess the efficacy and side-effects of TBZ in Huntington disease (HD), vascular chorea, tics, dystonia, oromandibular dyskinesia and other tardive syndromes (TS). Background:…
  • 2016 International Congress

    How do patients experience deep brain stimulation surgery: A prospective patient satisfaction survey

    A. Fazl, M. Gillego, A. Mogliner, M.H. Pourfar (New York, NY, USA)

    Objective: To evaluate experience of patients who undergo Deep Brain Stimulation (DBS) surgery for treatment of different movement disorders, using patient survey questionnaires. Background: DBS…
  • 2016 International Congress

    Tourette syndrome treated by continuous electrical neuromodulation (DBS): Targeting the comorbidities?

    F. Cyprien, L. Cif, V. Gonzalez, E. Sanrey, J. Perez, P. Coubes (Montpellier, France)

    Objective: To assess the response to deep brain stimulation (DBS) in refractory Tourette syndrome (rTS) of both tics and behavioural comorbidities. Background: Gilles de la…
  • 2016 International Congress

    Results from a double-blind trial of pallidal DBS for Tourette’s syndrome: Are there any predictors of surgery outcome?

    Z. Kefalopoulou, L. Zrinzo, M. Jahanshahi, J. Candelario, C. Milabo, M. Beigi, H. Akram, J. Hyam, J. Clayton, L. Kass-Iliyya, M. Silverdale, J. Evans, P. Limousin, M. Hariz, E. Joyce, T. Foltynie (London, United Kingdom)

    Objective: To explore whether individual patient characteristics can indicate response to treatment in a trial of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS)…
  • 2016 International Congress

    Phenomenology of dyskinesias induced by subthalamic stimulation in Tourette syndrome

    L.M. Romito, D. Calandrella, C. Bagella, G. Messina, F. Ferré, A. Franzini (Milan, Italy)

    Objective: To describe the phenomenology of dyskinesias induced by subthalamic (STN) stimulation in refractory Tourette syndrome (TS). Background: Dyskinesias occurring following hemorrhagic events in the…
  • 2016 International Congress

    Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis

    C. Bagella, D. Calandrella, G. Zorzi, G. Messina, F. Carella, A. Franzini, C.E. Marras, N. Nardocci, L.M. Romito (Milan, Italy)

    Objective: To analyze the long-term safety of Deep Brain Stimulation (DBS) procedures for patients with movement disorders. Background: DBS is currently indicated to treat several…
  • 2016 International Congress

    A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome

    J. Jankovic, J. Jimenez-Shahed, C. Budman, B. Coffey, T.K. Murphy, D. Shprecher, D. Stamler (Houston, TX, USA)

    Objective: This study explored the safety, tolerability and preliminary efficacy of SD-809 (deutetrabenazine) in adolescents with moderate to severe tics associated with Tourette syndrome (TS).…
  • 2016 International Congress

    Longitudinal follow-up of the association of tic disorders with poor academic performance

    E. Cubo, C. Gonzalez-Deza, V. Ausin, V. Delgado, S. Saez, X.R. Garcia-Soto, S. Calvo, J. Cordero, J.M. Trejo, J. Macarron, K. Kompoliti (Burgos, Spain)

    Objective: To analyze whether the presence of a tic disorder is associated with an increased risk for developing poor academic performance overtime. Background: Tic disorders…
  • 2016 International Congress

    Medical cannabis for the treatment of Tourette syndrome: A descriptive analysis of 24 patients

    S. Arad, L. Bar-Lev Schleider, J. Knaani, H. Shabtai, Y. Balash, A. Ezra, N. Giladi, T. Gurevich (Tel-Aviv, Israel)

    Objective: To assess the subjective effects of medical cannabis (MC) on patients with multiple treatment-resistant Tourette syndrome (TS). Background: Several single case studies and two…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley